GeoVax Labs SEC Filing Effectiveness Notice
Ticker: GOVX · Form: EFFECT · Filed: Apr 20, 2026 · CIK: 0000832489
Sentiment: neutral
Topics: sec-filing, effectiveness, pharmaceuticals
TL;DR
GeoVax filing effective 4/20/26. Act 33, File 333-281310.
AI Summary
GeoVax Labs, Inc. filed an EFFECT form on April 20, 2026, indicating the effectiveness of a filing related to Act 33, File No. 333-281310. The company's business address is 1955 Lake Park Drive, Suite 300, Smyrna, GA, with a contact number of 678-384-7220.
Why It Matters
This filing signifies that a previously submitted registration statement or other filing with the SEC has become effective, allowing GeoVax Labs to proceed with certain corporate actions.
Risk Assessment
Risk Level: low — This is a procedural filing indicating effectiveness, not a direct financial event.
Key Numbers
- 333-281310 — File Number (Associated with the EFFECT filing)
Key Players & Entities
- GeoVax Labs, Inc. (company) — Filer
- 0000832489 (company) — CIK
- 333-281310 (dollar_amount) — File Number
- 2026-04-20 (date) — Acceptance Date
- 2026-04-17 (date) — Effectiveness Date
FAQ
What type of filing is an 'EFFECT' form?
An 'EFFECT' form, as indicated in this filing, signifies that a registration statement or other filing submitted to the SEC has become effective.
When did this filing become effective?
The effectiveness date for this filing was April 17, 2026.
What is the CIK number for GeoVax Labs, Inc.?
The CIK number for GeoVax Labs, Inc. is 0000832489.
What is the business address of GeoVax Labs, Inc.?
The business address for GeoVax Labs, Inc. is 1955 Lake Park Drive, Suite 300, Smyrna, GA.
What is the SIC code for GeoVax Labs, Inc.?
The SIC code for GeoVax Labs, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 20, 2026 regarding GeoVax Labs, Inc. (GOVX).